Products.
The AMLprofiler in vitro diagnostic test simplifies the challenging task to recognize Acute Myeloid Leukemia (AML) subtypes and make individualized therapy decisions. The test determines relevant diagnostic and prognostic markers for AML in one single microarray-based assay. As compared to existing diagnostic methods, the AMLprofiler delivers faster results and significantly improved patient classification on a fully integrated and robust array platform.
-
AMLprofiler
The Most Efficient Diagnosis of Acute Myeloid Leukemia.The AMLprofiler simplifies the challenging task to recognize Acute Myeloid Leukemia subtypes and make individualized therapy decisions. It delivers faster results and improved patient classification on an integrated and validated array platform.
Read more >> -
Partnering for New Profilers
Skyline Diagnostics is the your partner of choice to transform gene signatures into a clinical tools. We are a leading company in translational development of gene signature-based diagnostics. Skyline markets its own diagnostic microarrays (Profilers) and collaborates with academic and industrial partners to launch develop and market new products.
Read more >> -
Pipeline
Read more >>
-
-
News
-
25/11/2011 - by T Dijkmans | Posted in: Events
A 7-hill Skyline
Last Sunday afternoon, Skyline Diagnostics took part in the ‘Zevenheuvelenloop’ run in Nijmegen, The Netherlands.
Read more -
13/10/2011 - by T. Dijkmans | Posted in: Events
Skyline attends the ESH-EHA Workshop
The ESH-EHA Scientific Workshop AML "Molecular" will be held from October 14 to 16 in Mandelieu La Napoule, France.
Read more -
30/09/2011 - by Thomas Dijkmans | Posted in: Events
Skyline participates in CTMM Annual meeting 2011
At the CTMM Annual Meeting, which took place on 29 September 2011 at the Jaarbeurs in Utrecht, over 400 people...
Read more
-
Dr. Molewaterplein 50, Suite Ee1971, 3015 GE Rotterdam. The Netherlands, Europe. Phone: +31 (0)10 7038410. Fax: +31 (0)10 7043076. E-mail: info@skyline-diagnostics.com
